Kabra Drugs Ltd. : Balance Sheet
Industry Phar BSE Code 524322 Face Value 10.00
Chairman NSE Code KABRADG Market Lot 1
Group Not Applicable ISIN No INE323K01017 Book Closure 30/09/2024
Rs. in Crs.
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
No. of Equity Shares (in Lacs)237.0843.8943.8943.8943.89
      
EQUITIES AND LIABILITIES     
SHAREHOLDER'S FUNDS     
Equity Share Capital23.714.394.394.394.39
Total Share Capital23.714.394.394.394.39
      
Reserves and Surplus0.95-5.86-5.12-4.78-4.60
Total Reserves and Surplus0.95-5.86-5.12-4.78-4.60
Total Shareholders Funds24.65-1.47-0.73-0.39-0.21
Equity Share Application Money0.002.550.000.000.00
Short Term Borrowings0.441.711.381.030.90
Trade Payables0.000.000.000.000.19
Other Current Liabilities0.141.780.050.100.52
Total Current Liabilities0.573.491.431.121.61
      
Total Capital And Liabilities25.234.570.700.731.40
      
ASSETS     
NON-CURRENT ASSETS     
Tangible Assets0.040.000.000.000.01
Fixed Assets0.040.000.000.000.01
Other Non-Current Assets0.020.020.020.020.02
Total Non-Current Assets0.070.020.020.020.03
      
      
CURRENT ASSETS     
Trade Receivables0.600.600.600.601.25
Cash And Cash Equivalents21.302.670.000.000.01
Short Term Loans And Advances0.000.040.040.070.07
OtherCurrentAssets3.261.230.030.030.03
Total Current Assets25.164.550.680.711.37
      
Total Assets25.234.570.700.731.40
      
OTHER INFORMATION     
      
CONTINGENT LIABILITIES, COMMITMENTS     
Contingent Liabilities0.490.000.000.000.48
  Company Info
Type first few letters